A New Method To Evaluate the Prognostic Value of Response to Prednisone Pre-Treatment in Adult (15–60 Yrs) Patients with Acute Lymphoblastic Leukemia: Results of the GIMEMA LAL 2000 Study

MLA

Federica Sorà, et al. “A New Method To Evaluate the Prognostic Value of Response to Prednisone Pre-Treatment in Adult (15–60 Yrs) Patients with Acute Lymphoblastic Leukemia: Results of the GIMEMA LAL 2000 Study.” Blood, vol. 106, Nov. 2005, p. 1829. EBSCOhost, https://doi.org/10.1182/blood.v106.11.1829.1829.

APA

Federica Sorà, Giovanna Meloni, Franco Mandelli, Ciro R. Rinaldi, Paola Fazi, Simona Iacobelli, Giuseppe Torelli, Alessandra Tedeschi, Vincenzo Liso, Felicetto Ferrara, Marco Vignetti, Francesco Di Raimondo, Giuseppe Fioritoni, Robert Foa, Salvatore Mirto, Francesco Nobile, & Federico Mosna. (2005). A New Method To Evaluate the Prognostic Value of Response to Prednisone Pre-Treatment in Adult (15–60 Yrs) Patients with Acute Lymphoblastic Leukemia: Results of the GIMEMA LAL 2000 Study. Blood, 106, 1829. https://doi.org/10.1182/blood.v106.11.1829.1829

Chicago

Federica Sorà, Giovanna Meloni, Franco Mandelli, Ciro R. Rinaldi, Paola Fazi, Simona Iacobelli, Giuseppe Torelli, et al. 2005. “A New Method To Evaluate the Prognostic Value of Response to Prednisone Pre-Treatment in Adult (15–60 Yrs) Patients with Acute Lymphoblastic Leukemia: Results of the GIMEMA LAL 2000 Study.” Blood 106 (November): 1829. doi:10.1182/blood.v106.11.1829.1829.